Strain Information | |
---|---|
Image | |
BRC No. | RBRC04395 |
Type | Targeted Mutation |
Species | Mus musculus |
Strain name | B6;129-Siglec1<tm1(HBEGF)Mtka> |
Former Common name | CD169-DTR KO |
H-2 Haplotype | |
ES Cell line | R1 [(129X1/SvJ x 129S1/Sv)F1-Kitl<+>] |
Background strain | |
Appearance | |
Strain development | 理化学研究所免疫・アレルギー科学総合研究所。R1 ES細胞を用いて作出。C57BL/6背景。 |
Strain description | CD169 (Siglec1) 遺伝子プロモーター下流にヒトジフテリア毒素受容体 (DTR) であるHB-EGF遺伝子を挿入したマウス。ジフテリア毒素 (DT) 投与により脾臓辺縁帯およびリンパ洞に局在するマクロファージ (CD169陽性マクロファージ) が消失する。 |
Colony maintenance | Homozygote x Homozygote [or Crossing to C57BL/6JJcl] |
References | Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. Miyake Y, Asano K, Kaise H, Uemura M, Nakayama M, Tanaka M J. Clin. Invest., 117, 2268-2278 (2007). 17657313Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. M Saito, T Iwawaki, C Taya, H Yonekawa, M Noda, Y Inui, E Mekada, Y Kimata, A Tsuru, K Kohno Nat. Biotechnol., 19, 746-750 (2001). 11479567Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Saito M, Iwawaki T, Taya C, Yonekawa H, Noda M, Inui Y, Mekada E, Kimata Y, Tsuru A, Kohno K Nat. Biotechnol., 19, 746-750 (2001). 11479567 |
Health Report | |
---|---|
Examination Date / Room / Rack | 2024/06/10Room:3-2Rack:B 2024/03/11Room:3-2Rack:B 2023/12/11Room:3-2Rack:B 2023/09/11Room:3-2Rack:B 2023/06/13Room:3-2Rack:B 2023/03/13Room:3-2Rack:B 2022/12/12Room:3-2Rack:B |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
HBEGF | heparin-binding EGF-like growth factor (human) | 2 | HBEGF | ||||
Siglec1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 2 | Siglec1 | targeted mutation 1, Masato Tanaka | |||
loxP | phage P1 loxP | 2 | loxP |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 1 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
供与核酸 | Human HB-EGF(DTR) cDNA, Phage P1 loxP site, Mouse Siglec1 genomic DNA |
Research application | Cre/loxP system Immunology and Inflammation Research |
提供条件 | 条件を付加する。利用者は事前に寄託者の提供承諾書を得る。 研究成果の公表にあたって寄託者の指定する文献を引用する。Nat. Biotechnol., 19, 746-750 (2001). J. Clin Invest., 117, 2268-2278 (2007). 研究成果の公表にあたっては、寄託者/開発者(Masato Tanaka, Ph.D.およびKenji Kohno, Ph.D.)へ謝辞の表明を必要とする。 |
Depositor | 田中 正人(独立行政法人理化学研究所) |
Strain Status | 生体 凍結胚 凍結精子 |
Strain Availability | 凍結精子を1ヶ月以内に提供可能 凍結胚を1ヶ月以内に提供可能 生体マウスを1~3ヶ月以内に提供可能 |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- Mouse of the Month Dec 2012 |
BRC mice in Publications |
---|
Chalot M, Barroca V, Devanand S, Hoffschir F, Romeo PH, Moreno SG. Deleterious effect of bone marrow-resident macrophages on hematopoietic stem cells in response to total body irradiation. Blood Adv 6(6) 1766-1779(2022) 35100346 |
Borriello F, Poli V, Shrock E, Spreafico R, Liu X, Pishesha N, Carpenet C, Chou J, Di Gioia M, McGrath ME, Dillen CA, Barrett NA, Lacanfora L, Franco ME, Marongiu L, Iwakura Y, Pucci F, Kruppa MD, Ma Z, Lowman DW, Ensley HE, Nanishi E, Saito Y, O'Meara TR, Seo HS, Dhe-Paganon S, Dowling DJ, Frieman M, Elledge SJ, Levy O, Irvine DJ, Ploegh HL, Williams DL, Zanoni I. An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity. Cell 185(4) 614-629.e21(2022) 35148840 |
Casella V, Domenjo-Vila E, Esteve-Codina A, Pedragosa M, Cebollada Rica P, Vidal E, de la Rubia I, López-Rodríguez C, Bocharov G, Argilaguet J, Meyerhans A. Differential kinetics of splenic CD169+ macrophage death is one underlying cause of virus infection fate regulation. Cell Death Dis 14(12) 838(2023) 38110339 |
Oh DS, Oh JE, Jung HE, Lee HK. Transient Depletion of CD169+ Cells Contributes to Impaired Early Protection and Effector CD8+ T Cell Recruitment against Mucosal Respiratory Syncytial Virus Infection. Front Immunol 8 819(2017) 28751894 |
Wang D, Li Q, Yang Y, Hao S, Han X, Song J, Yin Y, Li X, Tanaka M, Qiu CH. Macrophage Subset Expressing CD169 in Peritoneal Cavity-Regulated Mucosal Inflammation Together with Lower Levels of CCL22. Inflammation 40(4) 1191-1203(2017) 28466432 |
Jing W, Guo X, Wang G, Bi Y, Han L, Zhu Q, Qiu C, Tanaka M, Zhao Y. Breast cancer cells promote CD169+ macrophage-associated immunosuppression through JAK2-mediated PD-L1 upregulation on macrophages. Int Immunopharmacol 78 106012(2020) 31865052 |
Jing W, Qin F, Guo X, Sun Y, Yan C, Qiu C, Tanaka M, Shi B, Zhao Y. G-CSF mediates lung injury in mice with adenine-induced acute kidney injury. Int Immunopharmacol 63 1-8(2018) 30056257 |
Zhang J, Supakorndej T, Krambs JR, Rao M, Abou-Ezzi G, Ye RY, Li S, Trinkaus K, Link DC. Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. J Clin Invest 129(7) 2920-2931(2019) 31039135 |
Kim HJ, Park JH, Kim HC, Kim CW, Kang I, Lee HK. Blood monocyte-derived CD169+ macrophages contribute to antitumor immunity against glioblastoma. Nat Commun 13(1) 6211(2022) 36266311 |
Pirgova G, Chauveau A, MacLean AJ, Cyster JG, Arnon TI. Marginal zone SIGN-R1+ macrophages are essential for the maturation of germinal center B cells in the spleen. Proc Natl Acad Sci U S A 117(22) 12295-12305(2020) 32424104 |